EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Repurposing flubendazole for glioblastoma ferroptosis by affecting xCT and TFRC proteins

Wei Teng, Yuanguo Ling, Niya Long, Wu Cen, Hongzhi Zhang, Lishi Jiang, Jian Liu, Xingwang Zhou, Liangzhao Chu iD

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.70188 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Wei Teng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China. Hauptthemen laut MEDLINE: Ferroptosis, Mebendazole, Glioblastoma, Drug Repositioning. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guizhou Province Science and Technology Plan Project (Project), National Natural Science Foundation of China (NSFC), Affiliated Hospital of Guizhou Medical University, Guizhou Science and Technology Plan Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

New uses of old drugs hold great promise for clinical translation. Flubendazole, an FDA‐approved antiparasitic drug, has been shown to target p53 and promote apoptosis in glioblastoma (GBM) cells. However, its damaging mechanism in GBM remains elusive. Herein, we explored the ferroptosis‐inducing ability of flubendazole on GBM cells. After treating glioma cell lines U251 and LN229 with the flubendazole (DMSO

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisMebendazoleGlioblastomaDrug RepositioningAmino Acid Transport System y+Receptors, TransferrinHumansCell Line, TumorCell SurvivalReactive Oxygen SpeciesMembrane Potential, MitochondrialMolecular Docking SimulationGene Expression Regulation, NeoplasticBrain NeoplasmsApoptosis

Stichwörter der Autor:innen

Fubendazoleferroptosisglioblastomaglioblastoma stem cell

Substanzen

MebendazoleflubendazoleSLC7A11 protein, humanAmino Acid Transport System y+Receptors, TransferrinReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Neurosurgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
  • Department of Clinical Medicine, Guizhou Medical University, Guiyang, Guizhou, China.
  • Department of Neurosurgery, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.

ORCID-Profile: Liangzhao Chu

Förderung

  • Guizhou Province Science and Technology Plan Project (Project)
  • National Natural Science Foundation of China (NSFC), Affiliated Hospital of Guizhou Medical University
  • Guizhou Science and Technology Plan Project
  • National Natural Science Foundation of China
  • Science and Technology Fund project of Guizhou Provincial Health Commission

Zitieren

APA

Teng, W., Ling, Y., Long, N., Cen, W., Zhang, H., Jiang, L., Liu, J., Zhou, X., & Chu, L. (2024). Repurposing flubendazole for glioblastoma ferroptosis by affecting xCT and TFRC proteins. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70188

Vancouver

Teng W, Ling Y, Long N, Cen W, Zhang H, Jiang L, et al. Repurposing flubendazole for glioblastoma ferroptosis by affecting xCT and TFRC proteins. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70188

BibTeX
@article{Teng2024,
  author = {Teng, Wei and Ling, Yuanguo and Long, Niya and Cen, Wu and Zhang, Hongzhi and Jiang, Lishi and Liu, Jian and Zhou, Xingwang and Chu, Liangzhao},
  title = {Repurposing flubendazole for glioblastoma ferroptosis by affecting xCT and TFRC proteins},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.70188}
}
Kostenlos starten →